PRAC update on ongoing evaluation of myocarditis and pericarditis with COVID-19 vaccines, EMA

The PRAC requires further analysis of cases of myocarditis and/or pericarditis reported with all COVID-19 vaccines and is requesting additional data from manufacturers and is encouraging all healthcare professionals to report any cases.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news

Related Links:

Conditions:   Myocarditis;   Pericarditis Intervention:   Sponsor:   Ottawa Heart Institute Research Corporation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Information for healthcare professionals on myocarditis and pericarditis following COVID-19 vaccination.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
This study was performed to answer the urgent questions about the basic epidemiology and clinical course of myocarditis/pericarditis in hospitalized patients prior to the introduction of COVID-19 vaccines in pediatric population.METHODS: A retrospective medical record analysis including frequency, clinical characteristics, etiology and outcome of myocarditis/pericarditis was conducted in 17 years and younger patients who were hospitalized in two referral hospitals in Korea between 2010 and 2019.RESULTS: Total 142 patients with myocarditis (n = 119) and/or pericarditis (n = 23) were identified. Median age was 5.4 years (int...
Source: J Korean Med Sci - Category: General Medicine Authors: Source Type: research
This study investigates the incidence of myocarditis and pericarditis emergency department or inpatient hospital encounters before COVID-19 vaccine availability (January 2019 –January 2021) and during a COVID-19 vaccination period (February-May 2021) in a large US health care system.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research
The impact of the global health crisis due to the virus Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) —the causative pathogen of the coronavirus disease 2019 (COVID-19)—has begun to alter with the timely development, approval and administration of vaccines [1]. Although SARS-CoV-2 infection primarily targets the respiratory system [2–6], it is now recognised that the infection and its clinical manifestations are systemic [7–12], and also affecting the cardiovascular system of adults and children [13–20].
Source: Heart, Lung and Circulation - Category: Cardiology Authors: Tags: Editorial Source Type: research
The impact of the global health crisis due to the virus Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) —the causative pathogen of the coronavirus disease 2019 (COVID-19)—has begun to alter with the timely development, approval and administration of vaccines [1]. Although SARS-CoV-2 infection primarily targets the respiratory system [2–6], it is now recognised that the infection and its clinical manifestations are systemic [7–12], and also affecting the cardiovascular system of adults and children [13–20].
Source: Heart, Lung and Circulation - Category: Cardiology Authors: Tags: Editorial Source Type: research
This report (updated weekly) is based on analysis of data up to 14 July. It discusses overall safety and comments on specific reports, including thromboembolic events with thrombocytopenia, capillary leak syndrome, menstrual disorders, myocarditis/pericarditis, and others.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
More News: COVID-19 | Health | Myocarditis | Pericarditis | Vaccines